Page last updated: 2024-08-23

cefazolin and Cardiomyopathy, Hypertrophic

cefazolin has been researched along with Cardiomyopathy, Hypertrophic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jogia, D; Liang, M; Pasupati, S	1

Other Studies

1 other study(ies) available for cefazolin and Cardiomyopathy, Hypertrophic

Article	Year
Post-transcoronary ethanol septal ablation (TESA) infective endocarditis complicated by a ventricular septal defect. The Journal of invasive cardiology, 2011, Volume: 23, Issue:8 Topics: Anti-Bacterial Agents; Cardiomyopathy, Hypertrophic; Catheter Ablation; Cefazolin; Endocarditis; Endocardium; Ethanol; Heart Septal Defects, Ventricular; Heart Septum; Humans; Male; Middle Aged; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Ultrasonography	2011

Article

Year

Post-transcoronary ethanol septal ablation (TESA) infective endocarditis complicated by a ventricular septal defect.

The Journal of invasive cardiology, 2011, Volume: 23, Issue:8

Topics: Anti-Bacterial Agents; Cardiomyopathy, Hypertrophic; Catheter Ablation; Cefazolin; Endocarditis; Endocardium; Ethanol; Heart Septal Defects, Ventricular; Heart Septum; Humans; Male; Middle Aged; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Ultrasonography

2011